Skip to the page

Data / Form D filings / Cirrus Therapeutics, Inc.

Cirrus Therapeutics, Inc.: Form D filing

Cirrus Therapeutics, Inc., a technology company in Cambridge, MA, filed a Form D with the SEC in 2025. The latest, on August 19, 2025, reports $6.7 million sold of a $15.7 million offering to 8 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
750 Main Street, Cambridge, MA, 02139
Phone
(617) 959-3124
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2022
Revenue range
Not Applicable
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2078601

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 19, 2025New notice$15,698,319$6,698,321$8,999,9988Aug 4, 2025sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Alexandra CantleyDirector
Andrew DickDirector, Promoter
Khoo ShihDirector
Ying Kai ChanExecutive Officer, Director, Promoter

Other technology companies in Massachusetts that filed recently

Every Form D from the week of Aug 18, 2025 · All recent filings in Massachusetts · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Cirrus Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.